7-methylxanthine has been researched along with Nearsightedness in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, D; Guggenheim, J; Ribel-Madsen, S; Trier, K | 1 |
| Feldkaemper, M; Liu, H; Schaeffel, F; Trier, K | 1 |
| Tkatchenko, AV; Tkatchenko, TV | 1 |
| Jain, SK; Kaur, I; Paul, S; Sahajpal, NS; Singh, H | 1 |
| Arumugam, B; Hung, LF; Jong, M; Ostrin, L; Patel, N; Smith, EL; Trier, K | 1 |
| Ohno-Matsui, K; Vutipongsatorn, K; Yokoi, T | 1 |
| Chen, X; Cui, D; Ge, J; Hu, J; Trier, K; Wu, K; Yu, M; Zeng, J | 1 |
2 review(s) available for 7-methylxanthine and Nearsightedness
| Article | Year |
|---|---|
Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way.
Topics: Animals; Atropine; Drug Development; Eye; Humans; Myopia; Pharmacogenetics; Refraction, Ocular; Signal Transduction; Xanthines | 2019 |
Current and emerging pharmaceutical interventions for myopia.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Clinical Trials as Topic; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy; Humans; Ketorolac Tromethamine; Mydriatics; Myopia; Pharmaceutical Preparations; Riboflavin; Vitamin B Complex; Xanthines | 2019 |
5 other study(ies) available for 7-methylxanthine and Nearsightedness
| Article | Year |
|---|---|
Oral administration of caffeine metabolite 7-methylxanthine is associated with slowed myopia progression in Danish children.
Topics: Administration, Oral; Adolescent; Axial Length, Eye; Caffeine; Child; Denmark; Disease Progression; Humans; Myopia; Refraction, Ocular | 2023 |
Effects of 7-Methylxanthine on Deprivation Myopia and Retinal Dopamine Release in Chickens.
Topics: Animals; Animals, Newborn; Biomarkers; Chickens; Disease Models, Animal; Dopamine; Intravitreal Injections; Myopia; Refraction, Ocular; Retina; Xanthines | 2020 |
Sub-chronic and chronic toxicity evaluation of 7-methylxanthine: a new molecule for the treatment of myopia.
Topics: Animals; Caffeine; Myopia; Rats; Theobromine; Xanthines | 2022 |
The Adenosine Receptor Antagonist, 7-Methylxanthine, Alters Emmetropizing Responses in Infant Macaques.
Topics: Administration, Oral; Animals; Animals, Newborn; Anisometropia; Biometry; Disease Models, Animal; Emmetropia; Hyperopia; Macaca mulatta; Myopia; Purinergic P1 Receptor Antagonists; Xanthines | 2018 |
Effects of 7-methylxanthine on the sclera in form deprivation myopia in guinea pigs.
Topics: Animals; Animals, Newborn; Axial Length, Eye; Body Weight; Collagen; Disease Models, Animal; Guinea Pigs; Myopia; Purinergic P1 Receptor Antagonists; Refraction, Ocular; Sclera; Sensory Deprivation; Xanthines | 2011 |